Prionics has acquired Cedi-Diagnostics. The Dutch firm is a spin-off from the famous Wageningen University and Research Center (Wageningen UR). Through the purchase of Cedi, Prionics acquires a substantial number of new products and gains rights to commercialize developments made by the research center.

With this acquisition, Prionics has accomplished several objectives. "We have acquired a firm with tests proven on the market and we gain access to future developments of a unique global research center", says Dr Markus Moser, co-CEO of Prionics.
Cedi-Diagnostics, located in Lelystad, the Netherlands, develops and markets products for diagnostics in farm animals. With the acquired product portfolio - which includes diagnostics for bovine viral diarrhea and classical swine fever - Prionics will be able to offer a broader product portfolio to its customers. "The Cedi products are excellent tests which make an ideal addition to our existing portfolio of farm animal diagnostics", says Ernst Zollinger, Head of Marketing & Sales at Prionics.

Prionics affiliate
Prionics will also intensify its efforts in the development of future innovations in farm animal diagnostics through a strategic partnership with Wageningen UR.
Beginning June 2006, Cedi-Diagnostics will function as a Prionics affiliate and serve markets in the Benelux and Nordic countries.